Comparison of erbium:YAG and carbon dioxide lasers in resurfacing of facial rhytides.
OBJECTIVE
To compare the efficacy, adverse effects, and histological findings of erbium:YAG (Er:YAG) and carbon dioxide (CO2) laser treatment in removing facial rhytides.


METHODS
An intervention study of 21 subjects with facial rhytides. All participants were followed up for 6 months. The end points of the study were wrinkle improvement and duration of adverse effects.


METHODS
Academic referral center.


METHODS
Nineteen female and 2 male volunteers with skin type I to III and wrinkle class I to III participated in the study.


METHODS
In all subjects, 1 side of the face was treated with a CO2 laser and other side with an Er:YAG laser. Skin biopsies were performed in 6 subjects before treatment and immediately, 1 day, 2 days, and 6 months after treatment. Observations were recorded by subjects, investigators, and a blinded panel of experts.


METHODS
Improvement in wrinkles and severity and duration of adverse effects.


RESULTS
The CO2 laser-treated side had relatively better wrinkle improvement when evaluating all subjects (P<.03). However, in subjects receiving more than 5 passes of Er:YAG laser, improvement scores were not significantly different from those for 2 to 3 passes of CO2 laser treatment. Posttreatment erythema was noted at 2 weeks in 14 subjects (67%) on the Er:YAG laser-treated side and 20 subjects (95%) on the CO2 laser-treated side. The frequency of erythema was significantly less after Er:YAG laser treatment at 2 (P=.001) and 8 (P=.03) weeks. Hypopigmentation was seen in 1 Er:YAG-treated (5%) and 9 CO2-treated (43%) sides (chi2, P<.05). Histological evaluation showed residual thermal damage of up to 50 microm on the Er:YAG-treated side and up to 200 microm on the CO2-treated side.


CONCLUSIONS
Erbium:YAG laser is safe and effective in removing facial rhytides. Subjects treated with Er:YAG laser recover more quickly from the procedure than those receiving CO2 laser treatment.
Khatri
K A
KA
Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Ross
V
V
Grevelink
J M
JM
Magro
C M
CM
Anderson
R R
RR
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002245:Carbon Dioxide; D004871:Erbium; D005260:Female; D006801:Humans; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D015361:Rhytidoplasty / Q000379:methods*; D015595:Skin Aging / Q000473:pathology
D002245:Carbon Dioxide; D004871:Erbium